(1518–1542) Systemic Sclerosis and Related Disorders – Clinical Poster II

Poster abstract session.

Presentations:

• 1:00 PM – 3:00 PM Eastern Time

  Prevalence, Risk Factors and Treatment Patterns of Digital Ischemic Complications in Systemic Sclerosis: A Single Center Cross-Sectional Study
  

  Abstract Poster Presenter: Ashima Makol, MD – Mayo Clinic, Rochester, MN
• 1:00 PM – 3:00 PM Eastern Time

  Using Galacetin-3 (Gal-3) and Cardiotrophin-1 (CT-1) for Early Detection of Primary Heart Involvement in Systemic Sclerosis as Seen on Cardiac MRI
  

  Abstract Poster Presenter: Erin Chew, MD – Vanderbilt University Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Rituximab and Tocilizumab and Their Effect on Lung Disease Progression in Scleroderma. a Retrospective Cohort Study at a Single Centre
  

  Abstract Poster Presenter: Voon Ong, PhD, FRCP – UCL Medical School Royal Free Campus
• 1:00 PM – 3:00 PM Eastern Time

  Long-term Follow-Up of Participants of the Phase II Study That Evaluated Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis (ASSET Trial)
  

  Abstract Poster Presenter: Dinesh Khanna, MD, MSc – University of Michigan
• 1:00 PM – 3:00 PM Eastern Time

  The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Medication Use on Gastrointestinal Tract Symptoms in Early Disease
  

  Abstract Poster Presenter: Sarah Luebker, DO – Vanderbilt Medical University Cennter
• 1:00 PM – 3:00 PM Eastern Time

  Anti-RNPC3 Autoantibodies in Mixed Connective Tissue Disease Are Associated with Systemic Sclerosis Skin Involvement
  

  Abstract Poster Presenter: Darya S. Jalaledin, MD – Université de Sherbrooke
• 1:00 PM – 3:00 PM Eastern Time

  Risk Factors for Lung Function Decline in Systemic Sclerosis Interstitial Lung Disease in a Large Single-Center Cohort
  

  Abstract Poster Presenter: Ahmad Ramahi, MD, MPH – University of Michigan
• 1:00 PM – 3:00 PM Eastern Time

  Breakthrough Infections in COVID-19 Vaccinated Patients with Systemic Sclerosis: A Survival Analysis from a Multicenter International Patient-Reported Survey
  

  Abstract Poster Presenter: Sakir Ahmed, DM – Kalinga Institute of Medical Sciences
• 1:00 PM – 3:00 PM Eastern Time

  Developing a Screening Tool for the Detection of Interstitial Lung Disease in Systemic Sclerosis: The ILD-RISC Risk Score
  

  Abstract Poster Presenter: Cosimo Bruni, MD, PhD – University of Zurich & University of Florence
• 1:00 PM – 3:00 PM Eastern Time

  Maintained Complete B Cell Depletion Is Associated with Rituximab Efficacy in Connective Tissue Disorder Interstitial Lung Disease
  

  Abstract Poster Presenter: Jérôme Avouac, MD, PhD – Université de Paris Cité
• 1:00 PM – 3:00 PM Eastern Time

  Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) and Organ Damage: Data from the SENSCIS Trial
  

  Abstract Poster Presenter: Janet Pope, MD, FRCPC, MPH – University of Western Ontario
• 1:00 PM – 3:00 PM Eastern Time

  Clinical Nailfold Capillaroscopy Using Dinolite Microscope in Patients with Systemic Sclerosis
  

  Abstract Poster Presenter: Krishnasai Abhishek Madathanapalli, MBBS – University of Connecticut School of Medicine
• 1:00 PM – 3:00 PM Eastern Time

  Scleroderma Renal Crisis: Time to Initiation of Therapy Does Not Affect Mortality
  

  Abstract Poster Presenter: Aditi Patel, MD – Cleveland Clinic
• 1:00 PM – 3:00 PM Eastern Time

  Continued Treatment with Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Three-Year Data from SENSCIS-ON
  

  Abstract Poster Presenter: Yannick Allanore, MD – Université Paris Cité
• 1:00 PM – 3:00 PM Eastern Time

  The Primary Cardiomyopathy of Systemic Sclerosis on Cardiovascular Magnetic Resonance Imaging
  

  Abstract Poster Presenter: Sanya Chhikara, MBBS – Jacobi Medical Center
• 1:00 PM – 3:00 PM Eastern Time

  Use of Body Mass Index in Prediction of Interstitial Lung Disease Related to Systemic Sclerosis Revealed by Decision Trees
  

  Abstract Poster Presenter: Alexandru Garaiman, MD – University Hospital Zurich
• 1:00 PM – 3:00 PM Eastern Time

  Blood Flow Assessment of Digital Arterioles and Capillaries in Systemic Sclerosis Patients Using Ultra-high Resolution Doppler Ultrasounds
  

  Abstract Poster Presenter: Pietro Francesco Bica, MD – Università degli Studi di Genova
• 1:00 PM – 3:00 PM Eastern Time

  Frequency of Arrhythmias, Abnormal Electrocardiography and Sudden Cardiac Death in Systemic Sclerosis: A Systematic Review and Meta-analysis
  

  Abstract Poster Presenter: Jessica Fairley, MBBS, FRACP – The University of Melbourne
• 1:00 PM – 3:00 PM Eastern Time

  Progressive Interstitial Lung Disease Is Frequent Also in Late Disease Stages in Systemic Sclerosis Patients from EUSTAR
  

  Abstract Poster Presenter: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Proteomic Profiling of Plasma Microvesicles Isolated from Patients with Systemic Sclerosis
  

  Abstract Poster Presenter: Line Iversen, MD, PhD – Odense University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Decreased Prevalence of Autoimmune Connective Tissue Diseases in Type 1 and Type 2 Diabetes
  

  Abstract Poster Presenter: Aya Abugharbyeh, MD – University of Toledo
• 1:00 PM – 3:00 PM Eastern Time

  Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease
  

  Abstract Poster Presenter: Monica Yang, MD – UCSF
• 1:00 PM – 3:00 PM Eastern Time

  Correlations of Soluble Interleukin-2 Receptor Serum Levels with Markers of Inflammation and Pathological High-sensitivity Troponin T and Its Possible Role as a Predictor of Early Clinical Progress in Systemic Sclerosis
  

  Abstract Poster Presenter: Luise Schumacher, -None- – University of Lübeck, Germany
• 1:00 PM – 3:00 PM Eastern Time

  MRI Digital Artery Volume Index (DAVIX) Predicts Future Digital Ulcers and Disease Progression in Systemic Sclerosis
  

  Abstract Poster Presenter: Michael Hughes, PhD, MBBS, BSc, MSc, MRCP – Tameside and Glossop Integrated NHS Foundation Trust & The University of Manchester
• 1:00 PM – 3:00 PM Eastern Time

  Exploratory Clinical Subgroup Clustering in Systemic Sclerosis - Results from the Indian Progressive Systemic Sclerosis Registry
  

  Abstract Poster Presenter: Shery Susan Philip, MD, MBBS – St. John’s Medical College Hospital